Trainimal (TRML) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
18 Jun, 2026Executive summary
Achieved 11% year-over-year revenue growth to 11.95 MSEK for the full year, with a clear return to profitability and a net result of 550 TSEK, corresponding to an operating margin of 5.1%.
EBITDA increased nearly 50% to 3.2 MSEK, and operating cash flow more than tripled to 3.6 MSEK.
Membership gross margin improved to 75.1% from 73.9% year-over-year.
Q4 results were stable, with some customer caution due to global economic uncertainty, but profitability was maintained.
Continued product and technology development, including AI-powered app features and backend infrastructure improvements.
Financial highlights
Q4 net revenue: 3,077 TSEK (down from 3,118 TSEK year-over-year); full-year net revenue: 11,949 TSEK (up from 10,758 TSEK).
Q4 operating income: 244 TSEK (286 TSEK prior year); full-year operating income: 550 TSEK (-266 TSEK prior year).
Q4 EBITDA: 958 TSEK (914 TSEK prior year); full-year EBITDA: 3,170 TSEK (2,162 TSEK prior year).
Q4 pre-tax profit: 160 TSEK (331 TSEK prior year); full-year pre-tax profit: 355 TSEK (-245 TSEK prior year).
Q4 EPS: 0.07 SEK (0.14 SEK prior year); full-year EPS: 0.15 SEK (-0.10 SEK prior year).
Outlook and guidance
Customer caution observed in Q4 due to economic uncertainty, but signs of normalization from May onward.
Continued focus on technology enhancements and international expansion, particularly in the UK.
Latest events from Trainimal
- Sales up 19.8% year-over-year in Q3, with strong cash flow and margin improvements.TRML
Q3 25/2620 Mar 2026 - Q2 delivered robust sales growth, higher margins, and new medical partnerships, sustaining momentum.TRML
Q2 25/2619 Dec 2025 - Returned to profit in Q1 with higher margins, lower CAC, and strong cash flow.TRML
Q1 25/2619 Sep 2025 - Q4 saw a return to profitability, record margins, and strong cost discipline, setting up for future growth.TRML
Q4 24/2519 Jun 2025 - EBITDA and subscription margins improved, with positive cash flow and global expansion plans.TRML
Q2 24/2513 Jun 2025 - Net sales and ARPU fell, but gross margin and recurring revenue stayed robust.TRML
Q1 24/2513 Jun 2025 - EBITDA turned positive and customer numbers hit a record after the new app launch.TRML
Q4 23/2413 Jun 2025 - Gross margin and EBITDA improved despite lower sales, with positive cash flow achieved.TRML
Q3 24/256 Jun 2025